Stockreport

Celldex Therapeutics Touts Barzolvolimab Phase III CSU Momentum, Lays Out 2026 Data Catalysts [Yahoo! Finance]

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF in 43 countries — six months ahead of schedule — and Celldex expects a sequence of 2026 readouts led by prurigo nodularis in summer and the Phase III CSU readout in Q4 2 [Read more]